K, D., GK, L., V, A., A, M., FJ, B., A, D., . . . DA, B. (2016). Marizomib activity as a single agent in malignant gliomas: Ability to cross the blood-brain barrier. Neuro-oncology, 18(6), 840. https://doi.org/10.1093/neuonc/nov299
Chicago Style (17th ed.) CitationK, Di, Lloyd GK, Abraham V, MacLaren A, Burrows FJ, Desjardins A, Trikha M, and Bota DA. "Marizomib Activity as a Single Agent in Malignant Gliomas: Ability to Cross the Blood-brain Barrier." Neuro-oncology 18, no. 6 (2016): 840. https://doi.org/10.1093/neuonc/nov299.
MLA (9th ed.) CitationK, Di, et al. "Marizomib Activity as a Single Agent in Malignant Gliomas: Ability to Cross the Blood-brain Barrier." Neuro-oncology, vol. 18, no. 6, 2016, p. 840, https://doi.org/10.1093/neuonc/nov299.